Mainuddin Ahmed
Medical Oncology · Tullahoma, TNNPI 1790739688
Payments from drug & device makers
Across 139 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$296
- Merck$243
- Incyte Corporation$183
- Exelixis Inc.$122
- E.r. Squibb & Sons, L.L.C.$116
- Astellas Pharma US Inc$112
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,10488%
- Education$29412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 14 | $296 |
| Merck | 16 | $243 |
| Incyte Corporation | 9 | $183 |
| Exelixis Inc. | 6 | $122 |
| E.r. Squibb & Sons, L.L.C. | 9 | $116 |
| Astellas Pharma US Inc | 4 | $112 |
| Bayer | 7 | $109 |
| Sanofi | 8 | $109 |
| Novartis | 7 | $98 |
| Daiichi Sankyo Inc. | 5 | $94 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Amgen | 6 | $84 |
| Eisai Inc. | 5 | $80 |
| Bristol Myers Squibb | 4 | $78 |
| Tesaro, Inc. | 2 | $52 |
| Johnson & Johnson | 3 | $51 |
| Pfizer | 4 | $50 |
| Genentech USA, Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Gilead(2 entities) | 3 | $41 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $41 |
| Puma Biotechnology, Inc. | 2 | $34 |
| Dova Pharmaceuticals | 2 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Rigel Pharmaceuticals, Inc. | 1 | $21 |
| Taiho Oncology, Inc. | 1 | $20 |
| Clovis Oncology, Inc. | 1 | $18 |
| Array Biopharma Inc | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Seagen Inc. | 1 | $14 |
| Foundation Medicine, Inc. | 1 | $12 |
| Mylan Institutional Inc. | 1 | $11 |
| Ipsen Biopharmaceuticals, Inc | 1 | $11 |
How this compares
$2,399 in reported general payments places this provider in the 25th percentile of 101 medical oncology providers in Tennessee.
Other medical oncology in Tullahoma
- Melissa JohnsonNashville$46M
- David SpigelNashville$29.7M
- Gregory VidalGermantown$12.5M
- Howard BurrisNashville$12.2M
- Ingrid MayerNashville$6.3M
- Daniel VaenaGermantown$5M
- Ari VanderwaldeGermantown$4.9M
- Gina VaccaroCookeville$4.8M
- Jennifer ChoeNashville$4.1M
- Cathy EngNashville$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.